{
    "organizations": [],
    "uuid": "99e0ec281ae24b5f6f6549ac60d9a9af3f0bb405",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-miragen-therapeutics-announces-pro/brief-miragen-therapeutics-announces-proposed-public-offering-of-common-stock-idUSASB0C3VY",
    "ord_in_thread": 0,
    "title": "BRIEF-miRagen Therapeutics Announces Proposed Public Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 5 (Reuters) - Miragen Therapeutics Inc:\n* MIRAGEN THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK\n* SAYS OFFERING 7.00 MILLION COMMON SHARES * MIRAGEN THERAPEUTICS - TO USE PROCEEDS FROM OFFERING FOR WORKING CAPITAL PURPOSES INCLUDING FUNDING OF PRODUCT CANDIDATES​’ CLINICAL DEVELOPMENT Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-05T19:23:00.000+02:00",
    "crawled": "2018-02-07T00:08:27.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "miragen",
        "therapeutic",
        "inc",
        "miragen",
        "therapeutic",
        "announces",
        "proposed",
        "public",
        "offering",
        "common",
        "stock",
        "say",
        "offering",
        "million",
        "common",
        "share",
        "miragen",
        "therapeutic",
        "use",
        "proceeds",
        "offering",
        "working",
        "capital",
        "purpose",
        "including",
        "funding",
        "product",
        "clinical",
        "development",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}